|
1
|
El-Serag HB: Epidemiology of viral
hepatitis and hepatocellular carcinoma. Gastroenterology.
142:1264.e1–1273.e1. 2012. View Article : Google Scholar
|
|
2
|
de Lope CR, Tremosini S, Forner A, Reig M
and Bruix J: Management of HCC. J Hepatol. 56(Suppl 1): S75–S87.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Osaki Y and Nishikawa H: Treatment for
hepatocellular carcinoma in Japan over the last three decades: our
experience and published work review. Hepatol Res. Jun
26–2014.(Epub ahead of print). View Article : Google Scholar
|
|
4
|
Zhou WP, Lai EC, Li AJ, Fu SY, Zhou JP,
Pan ZY, Lau WY and Wu MC: A prospective, randomized, controlled
trial of preoperative transarterial chemoembolization for
resectable large hepatocellular carcinoma. Ann Surg. 249:195–202.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Nishikawa H, Osaki Y, Kita R, Kimura T,
Inuzuka T, Takeda H, Nakajima J, Matsuda F, Sakamoto A, Henmi S,
Hatamaru K, Saito S and Nasu A: Transcatheter arterial infusion
chemotherapy prior to radiofrequency thermal ablation for single
hepatocellular carcinoma reduces the risk of intrahepatic distant
recurrence. Int J Oncol. 41:903–909. 2012.PubMed/NCBI
|
|
6
|
Kudo M, Todo A, Ikekubo K and Hino M:
Receptor index via hepatic asialoglycoprotein receptor imaging:
correlation with chronic hepatocellular damage. Am J Gastroenterol.
87:865–870. 1992.PubMed/NCBI
|
|
7
|
Matsuzaki S, Onda M, Tajiri T and Kim DY:
Hepatic lobar differences in progression of chronic liver disease:
correlation of asialoglycoprotein scintigraphy and hepatic
functional reserve. Hepatology. 25:828–832. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kaibori M, Ha-Kawa SK, Maehara M, Ishizaki
M, Matsui K, Sawada S and Kwon AH: Usefulness of Tc-99m-GSA
scintigraphy for liver surgery. Ann Nucl Med. 25:593–602. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ogasawara G, Inoue Y, Itoh Y, Tagami S,
Matsunaga K and Miki K: Improved reproducibility of simple
quantitative indices from 99mTc-GSA liver functional
imaging. Ann Nucl Med. 27:487–491. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Harada K, Mizuguchi T, Katagiri Y,
Kawamoto M, Nakamura Y, Meguro M, Ota S, Sasaki S, Miyanishi K,
Sonoda T, Mori M, Shinomura Y, Kato J and Hirata K: Area between
the hepatic and heart curves of 99mTc-galactosyl-human
serum albumin scintigraphy represents liver function and disease
progression for preoperative evaluation in hepatocellular carcinoma
patients. J Hepatobiliary Pancreat Sci. 19:667–673. 2012.
View Article : Google Scholar
|
|
11
|
Kubota K, Makuuchi M, Kusaka K, Kobayashi
T, Miki K, Hasegawa K, Harihara Y and Takayama T: Measurement of
liver volume and hepatic functional reserve as a guide to
decision-making in resectional surgery for hepatic tumors.
Hepatology. 26:1176–1181. 1997.PubMed/NCBI
|
|
12
|
Gupta S, Chawla Y, Kaur J, Saxena R,
Duseja A, Dhiman RK and Choudhary NS: Indocyanine green clearance
test (using spectrophotometry) and its correlation with model for
end stage liver disease (MELD) score in Indian patients with
cirrhosis of liver. Trop Gastroenterol. 33:129–134. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yoshizumi T, Taketomi A, Uchiyama H,
Harada N, Kayashima H, Yamashita Y, Soejima Y, Shimada M and
Maehara Y: Graft size, donor age, and patient status are the
indicators of early graft function after living donor liver
transplantation. Liver Transpl. 14:1007–1013. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Alberti KG and Zimmet PZ: Definition,
diagnosis and classification of diabetes mellitus and its
complications. Part 1: diagnosis and classification of diabetes
mellitus provisional report of a WHO consultation. Diabet Med.
15:539–553. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kinoshita K, Ukikusa M, Iwaisako K,
Arimoto A, Fujisawa N, Ozaki T, Tanaka H, Seo S, Naitoh M, Nomura
A, Inomoto T, Kitai T, Ino K, Higashiyama H, Hanafusa T and
Nakajima Y: Preoperative assessment of hepatic function: utility of
a new convenient two-compartment model analysis using galactosyl
human serum albumin scintigraphy. J Gastroenterol. 18:99–104.
2003.
|
|
16
|
Wai CT, Greenson JK, Fontana RJ,
Kalbfleisch JD, Marrero JA, Conjeevaram HS and Lok AS: A simple
noninvasive index can predict both significant fibrosis and
cirrhosis in patients with chronic hepatitis C. Hepatology.
38:518–526. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sterling RK, Lissen E, Clumeck N, Sola R,
Correa MC, Montaner J, Sulkowski MS, Torriani FJ, Dieterich DT,
Thomas DL, Messinger D and Nelson M; APRICOT Clinical
Investigators. Development of a simple noninvasive index to predict
significant fibrosis in patients with HIV/HCV coinfection.
Hepatology. 43:1317–1325. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bruix J and Sherman M; Practice Guidelines
Committee, American Association for the Study of Liver Diseases.
Management of hepatocellular carcinoma. Hepatology. 42:1208–1236.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
No authors listed. The general rules for
the clinical and pathological study of primary liver cancer. Liver
Cancer Study Group of Japan. Jpn J Surg. 19:98–129. 1989.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Utsunomiya T, Shimada M, Kudo M, Ichida T,
Matsui O, Izumi N, Matsuyama Y, Sakamoto M, Nakashima O, Ku Y,
Takayama T and Kokudo N; for the Liver Cancer Study Group of Japan.
A comparison of the surgical outcomes among patients with
HBV-positive, HCV-positive, and non-B non-C hepatocellular
carcinoma: a nationwide study of 11,950 patients. Ann Surg. Jul
28–2014.(Epub ahead of print). PubMed/NCBI
|
|
21
|
Shen SL, Fu SJ, Chen B, Kuang M, Li SQ,
Hua YP, Liang LJ, Guo P, Hao Y and Peng BG: Preoperative aspartate
aminotransferase to platelet ratio is an independent prognostic
factor for hepatitis B-induced hepatocellular carcinoma after
hepatic resection. Ann Surg Oncol. 21:3802–3809. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Makuuchi M: Surgical treatment for HCC -
special reference to anatomical resection. Int J Surg. 11(Suppl 1):
S47–S49. 2013. View Article : Google Scholar
|
|
23
|
Shindoh J, Hasegawa K, Inoue Y, Ishizawa
T, Nagata R, Aoki T, Sakamoto Y, Sugawara Y, Makuuchi M and Kokudo
N: Risk factors of post-operative recurrence and adequate surgical
approach to improve long-term outcomes of hepatocellular carcinoma.
HPB. 15:31–39. 2013. View Article : Google Scholar :
|
|
24
|
Angulo P, Bugianesi E, Bjornsson ES,
Charatcharoenwitthaya P, Mills PR, Barrera F, Haflidadottir S, Day
CP and George J: Simple noninvasive systems predict long-term
outcomes of patients with nonalcoholic fatty liver disease.
Gastroenterology. 145:782.e4–789.e4. 2013. View Article : Google Scholar
|
|
25
|
Lin ZH, Xin YN, Dong QJ, Wang Q, Jiang XJ,
Zhan SH, Sun Y and Xuan SY: Performance of the aspartate
aminotransferase-to-platelet ratio index for the staging of
hepatitis C-related fibrosis: an updated meta-analysis. Hepatology.
53:726–736. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Smith JO and Sterling RK: Systematic
review: non-invasive methods of fibrosis analysis in chronic
hepatitis C. Aliment Pharmacol Ther. 30:557–576. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Joo SK, Kim JH, Oh S, Kim BG, Lee KL, Kim
HY, Jung YJ, Woo HS, Moon MH, Chang MS and Kim W: Prospective
comparison of noninvasive fibrosis assessment to predict advanced
fibrosis or cirrhosis in Asian patients with hepatitis C. J Clin
Gastroenterol. Sep 8–2014.(Epub ahead of print). View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Vergniol J, Boursier J, Coutzac C,
Bertrais S, Foucher J, Angel C, Chermak F, Hubert IF, Merrouche W,
Oberti F, de Lédinghen V and Calès P: Evolution of noninvasive
tests of liver fibrosis is associated with prognosis in patients
with chronic hepatitis C. Hepatology. 60:65–76. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Xiao G, Yang J and Yan L: Comparison of
diagnostic accuracy of APRI and FIB-4 for detecting liver fibrosis
in adult patients with chronic hepatitis B virus infection: a
systemic review and meta-analysis. Hepatology. Aug 18–2014.(Epub
ahead of print). View Article : Google Scholar
|
|
30
|
Nalbantoglu I and Brunt EM: Role of liver
biopsy in nonalcoholic fatty liver disease. World J Gastroenterol.
20:9026–9037. 2014.PubMed/NCBI
|
|
31
|
Castera L, Vilgrain V and Angulo P:
Noninvasive evaluation of NAFLD. Nat Rev Gastroenterol Hepatol.
10:666–675. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Castera L: Transient elastography and
other noninvasive tests to assess hepatic fibrosis in patients with
viral hepatitis. J Viral Hepat. 16:300–314. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lim KC, Chow PK, Allen JC, Chia GS, Lim M,
Cheow PC, Chung AY, Ooi LL and Tan SB: Microvascular invasion is a
better predictor of tumor recurrence and overall survival following
surgical resection for hepatocellular carcinoma compared to the
Milan criteria. Ann Surg. 254:108–113. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Chen CH, Hu FC, Huang GT, Lee PH, Tsang
YM, Cheng AL, Chen DS, Wang JD and Sheu JC: Applicability of
staging systems for patients with hepatocellular carcinoma is
dependent on treatment method - analysis of 2,010 Taiwanese
patients. Eur J Cancer. 45:1630–1639. 2009. View Article : Google Scholar : PubMed/NCBI
|
